
Genexpath team

A word from the CEO
Genexpath team is multidisciplinary. It brings together very different and complementary profiles in product development's section. We carry out the production and the quality control of the products in our premises of Rouen, in Normandy. Computer applications are also produced internally, with the help of consultants to support us and enable us to best meet user expectations.
Juliette Renauld, CEO
Juliette Renauld
Graduated from NEOMA BUSINESS SCHOOL in 2000, Juliette Renauld has been an entrepreneur since 2005 and has managed several companies. She notably founded the companies Gestion Juste and Cam Conseil and co-directed the company Interactive Biosoftware for 6 years. Since 2006, she has worked regularly in the field of innovation, both in support and in the development of her own projects, particularly in the field of genetics.
Rébecca Niss

Sales manager with an international profile, she manages Genexpath's commercial activity and ensures rigorous customer follow-up.
Laurine Becquet

Holder of a doctorate in Life and Health Sciences specializing in immunology, she is in charge of product development and production monitoring. She also manages the regulatory activity of the company.
Thomas Denoncin

Computer engineer, he is responsible for the development of all applications and their improvements.

Henri Becquerel Cancer center team
The researchers team Henri Becquerel Center, linked to INSERM Unit 1245, is behind the work that led to the development of the products marketed by Genexpath. They step in on a regular basis and allow the continuous improvement of the products. They also contribute to the development of the company's future products.
Philippe Ruminy
Holder of a doctorate in biology as well as an accreditation to direct research, Philippe Ruminy joined the genetics research team of the Henri Becquerel Cancer center, in Rouen, in 2001. His main field of expertise is the genetics of lymphoid hemopathies, in particular lymphomas. He is the main inventor of several patents relating to innovative diagnostic methods and classification algorithms based on artificial intelligence.

Pierre-Julien Viailly
Holder of a doctorate in biology and a master's degree in bioinformatics, Pierre-Julien Viailly joined the Henri Becquerel Cancer Center (Rouen) in 2014 to develop bioinformatics tools in connection with the acquisition of a high throughput sequencing platform. He has since participated in numerous research projects in connection with the INSERM U1245 research unit around these new technologies and has contributed to the development of the software GenerateReports. Il participe activement au développement de l’ensemble des outils informatiques de Genexpath.
Vinciane Rainville
Graduated in molecular biology, Vinciane has been a research technician at the Henri Becquerel center since 2005. She notably participated in the development of RT-MLPA and its development towards NGS. Specializing in lymphoma, Vinciane is an expert in the Genexpath LymphoSign kit.
Marie-Delphine Lanic
Marie-Delphine Lanic holds a Master's degree in oncology and has used her university years and professional experience to develop her scientific and technical knowledge in the fields of oncology and innovative therapies. Thanks to her specialization in solid tumors, she participated in the development of the technique for detecting fusion transcripts in sarcomas.
Mathieu Viennot
Graduated in biology, Mathieu Viennot acquired his experience, among other things in quality and metrology, thanks to his career in several private laboratories and in the laboratory of biopathology integrated into cancer at the Henri Becquerel center. He participates extensively in Genexpath's work for CE-IVD marking and certification.